Long-Term Outcome and Rejection After Allogeneic Uterus Transplantation in Cynomolgus Macaques

食蟹猴同种异体子宫移植后的长期结果和排斥反应

阅读:6
作者:Iori Kisu ,Hirohito Ishigaki ,Katsura Emoto ,Yojiro Kato ,Yohei Yamada ,Kentaro Matsubara ,Hideaki Obara ,Yohei Masugi ,Yusuke Matoba ,Masataka Adachi ,Kouji Banno ,Yoko Saiki ,Iori Itagaki ,Ikuo Kawamoto ,Chizuru Iwatani ,Takahiro Nakagawa ,Hideaki Tsuchiya ,Takako Sasamura ,Hiroyuki Urano ,Masatsugu Ema ,Kazumasa Ogasawara ,Daisuke Aoki ,Kenshi Nakagawa ,Takashi Shiina

Abstract

Uterus transplantation (UTx) is an option for women with uterine factor infertility to have a child, but is still in the experimental stage. Therefore, allogeneic animal models of UTx are required for resolution of clinical issues. In this study, long-term outcomes were evaluated in four recipients (cases 1-4) after allogeneic UTx in cynomolgus macaques. Immunosuppression with antithymocyte globulin induction and a triple maintenance regimen was used. Postoperative ultrasonography and biopsy of the transplanted uterus and immunoserological examinations were performed. All four recipients survived for >3 months after surgery, but continuous menstruation did not resume, although temporary menstruation occurred (cases 1 and 2). All animals were euthanized due to irreversible rejection and no uterine blood flow (cases 1, 2 and 4) and post-transplant lymphoproliferative disorder (case 3). Donor-specific antibodies against MHC class I and II were detected in cases 1, 2 and 4, but not in case 3. Peripheral lymphocyte counts tended to elevate for CD3+, CD20+ and NK cells in conjunction with uterine rejection, and all animals had elevated stimulation indexes of mixed lymphocyte reaction after surgery. Establishment of allogeneic UTx in cynomolgus macaque requires further exploration of immunosuppression, but the clinicopathological features of uterine rejection are useful for development of human UTx.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。